Variables | Normal endometrium | Benign diseases | Hyperplasia | Endometrial cancer (EC) | |
---|---|---|---|---|---|
Type I | Type II | ||||
Number of cases | 12 | 20 | 18 | 30 | 16 |
Age (years) | 53.4 ± 5.6 | 46.2 ± 5.8 | 46.4 ± 6.5 | 55.3 ± 6.9 | 59.6 ± 8.7 |
Subtypes | |||||
 Adenomyosis |  | 1 (5%) |  |  |  |
 Leiomyoma |  | 10 (50%) |  |  |  |
 Adenomyosis and leiomyoma |  | 9 (45%) |  |  |  |
 Endometrial hyperplasia |  |  | 12 (42.9%) |  |  |
 Atypical endometrial hyperplasia |  |  | 6 (33.3%) |  |  |
Histotypes of cancer | |||||
 Endometrioid |  |  |  | 30 (100%) | 3 (18.8%) |
 Serous |  |  |  | 0 | 6 (37.5%) |
 Others |  |  |  | 0 | 7 (43.8%) |
FIGO stage of cancer | |||||
 I |  |  |  | 28 (93.3%) | 10 (62.5%) |
 II |  |  |  | 0 | 1 (6.2%) |
 III |  |  |  | 1 (3.3%) | 3 (18.8%) |
 IV |  |  |  | 1 (3.3%) | 2 (12.5%) |
Histological grade of cancer | |||||
 G1 |  |  |  | 20 (66.7%) | 4 (25.0%) |
 G2 |  |  |  | 8 (26.7%) | 2 (12.5%) |
 G3 |  |  |  | 0 | 9 (56.2%) |
 Unknown |  |  |  | 2 (6.7%) | 1 (6.2%) |